Setting-up Your Drug for Clinical Success: Strategies and Considerations from Discovery to Clinic
The pharmaceutical industry continues to experience decreasing productivity and high levels of attrition. Inflation of molecule physicochemical properties and complexities in clinical trial protocols stand among the main reasons for these trends. The most successful companies can leverage different expertise, manage risks, and follow logical sequences of operations in an integrated manner to speed development.
This event will focus on key considerations for transitioning a molecule from discovery through clinical studies including molecule developability assessment, phase-appropriate formulation selection, integration of product development and clinical supply, and creating an appropriate clinical study design.
How does it work?
- Register and publish your collaboration profile.
- Browse Catalent's participant list and book meetings with the ones you are most interested in. There will be ample time for informal meetings.
- A few days before the event you receive your meeting schedule.